HomeNews

News

News

Key Challenges and Therapy Insights

Editor -
Dr. Breelyn Wilky, an affiliate professor of drugs within the Division of Medical Oncology on the College of Colorado, Anschutz Medical Campus, explains...
News

A Survivor and Affected person Advocate Displays on Beating Most cancers Twice

Editor -
Daniel Jernazian, a two-time most cancers survivor, shares what formed his journey by means of sickness and restoration.After being recognized with Hodgkin lymphoma...
News

Celebrating Survival After Transplant: Appreciating My Donor

Editor -
Mary Sansone is a two-time survivor of acute myeloid leukemia. Make amends for all of Mary's blogs right here!On June 5, 2025, I used...
News

Understanding Therapeutic Choices for ER+/HER2- Metastatic Breast Most cancers

Editor -
Consultants talk about remedy choices for these with ER-positive, HER2-negative stage 4 breast most cancers: © inventory.adobe.com.For sufferers navigating a prognosis of estrogen...
News

FDA Approves Stoboclo and Osenvelt as Biosimilars Throughout Some Cancers

Editor -
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are actually accessible: © inventory.adobe.com.Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia (denosumab) and...
1...272273274...672Page 273 of 672

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.